Unicycive Therapeutics Inc (US: UNCY) — Healthcare · Share Price, Chart & Market Data
About: Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases in the United States. It develops oxylanthanum carbonate, a lanthanum-based phosphate binding agent, which is for the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis; and UNI-494, a nicotinamide ester derivative and a selective ATP-sensitive mitochondrial potassium channel activator, which is in Phase I clinical trial for the treatment of acute kidney injury and pre-clinical stage for the treatment of chronic kidney disease. The company was incorporated in 2016 and is headquartered in Mountain View, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $7.16 (-0.14%)
UNCYUnicycive Therapeutics Inc
Loading watchlist status…
Trade UNCY now
Unicycive Therapeutics Inc share price
UNCY price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
30 Apr, 12:09 pm GMT+0
UNCY price performance
-1.783%
5D
17.185%
1M
23.448%
YTD
9.816%
1Y
UNCY price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
30 Apr, 12:09 pm GMT+0
UNCY details
UNCY Market Signals